聚焦艾昆纬-如果更好的减肥药物不断改善,消费者健康将重塑(英)-2026。-3.1% with placebo.15 These are not marginal effects. At the higher end, they are large enough to move many patients out of obesity if treatment is sustained.wealthy Western markets, depending on the baseline prevalence. In a U.S.-like market with obesity prevalence close to 40%, the upper end could be somewhat higher.
聚焦艾昆纬-如果更好的减肥药物不断改善,消费者健康将重塑(英)-2026。-3.1% with placebo.15 These are not marginal effects. At the higher end, they are large enough to move many patients out of obesity if treatment is sustained.wealthy Western markets, depending on the baseline prevalence. In a U.S.-like market with obesity prevalence close to 40%, the upper end could be somewhat higher.
聚焦艾昆纬-如果更好的减肥药物不断改善,消费者健康将重塑(英)-2026。-3.1% with placebo.15 These are not marginal effects. At the higher end, they are large enough to move many patients out of obesity if treatment is sustained.wealthy Western markets, depending on the baseline prevalence. In a U.S.-like market with obesity prevalence close to 40%, the upper end could be somewhat higher.
覆盖 2026 年,全文共 19 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
适合行业研究员等读者参考。
重点分析了消费者、健康、药物、艾昆纬等议题。